VIB INKS QBASE+ GROUP LICENSING AGREEMENT WITH BIOGAZELLE: http://t.co/EkimyQQSZW
posted
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Applied Maths has strengthened its sales team with the appointment of Koen De Roo as Director of Sales. read more
Galapagos NV (Euronext: GLPG) and Ono Pharmaceutical Co., Ltd. (TSE: 4528) announced today that they have signed an additional collaboration agreement focused on discovering novel targets in the field of allergic diseases including atopic dermatitis and bronchial asthma. In the new agreement, Galapagos' service division BioFocus will use its SilenceSelect® platform to deliver validated targets to Ono. Ono aims to find modulators for these targets and generate novel drug candidates. Financial details were undisclosed. read more
reMYND NV today announced that its shareholders have elected Ajit Shetty to join the company’s 4-person Board as an Independent Director. read more
The US Patent Office is willing to grant PharmaNeuroBoost (PNB) a patent for its third product being developed from her Boosting Technology Platform: PNB03. The FDA has approved the Phase III study for PNB’s firs product PNB01, for treatment of Major Depression. Already 250 out of 555 patients are being treated in the 32 American and Canadian centers participating in the study. read more
Kattenaids (FIV) tast, net zoals HIV bij de mens, het immuunsysteem aan. Daardoor wordt een besmette kat vatbaar voor allerlei infecties die uiteindelijk dodelijk kunnen zijn. Tot nog toe was er geen behandeling voor de ziekte, maar daar komt nu verandering in. read more
Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full IP rights, with access to IP created during the scope of this collaboration. read more
ThromboGenics NV (NYSE Euronext: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, announced today a capital increase arising from employee warrant exercises. read more
Patrik De Haes has been appointed as the new chairman of the Board of Directors of FlandersBio. He succeeds Johan Cardoen who stands down after five years in the post. Patrik De Haes, who is the CEO of ThromboGenics, has been a director of FlandersBio for the last two years. read more
MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced it has presented data demonstrating that its epigenetic ConfirmMDx™ for Prostate Cancer test can aid urologists in identifying patients who may avoid a repeat prostate biopsy. read more
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, is happy to welcome Ms. Karin Dorrepaal, PhD, MBA as its new Non-Executive Director. read more
